Professor Diana Anderson currently holds the Established Chair of the Division of Biomedical Sciences at the University of Bradford, UK. She obtained her first degree in the University of Wales and second degrees in the Faculty of Medicine, University of Manchester. After tutoring at the University of Sydney, Australia, she became a research worker in the Department of Cancer Studies at the University of Leeds and at the Paterson Laboratories, Christie Hospital, Manchester. In 1974, she was appointed as Head of Mutagenesis Studies at ICI’s Central Toxicology Laboratory. She joined BIBRA International in 1981 as Head of Genetic and Reproductive Toxicology and became Assistant Director and Group Forum Co-ordinator in 1987. In 1992, she became Senior Associate and Co-ordinator of External Affairs at BIBRA. She has attended various management courses. She has served on the editorial board of 8 international journals plus 2 on line journals, has over 400 publications, has edited/authored 8 books and guest-edited 9 special issues of 4 international journals. She is Series Editor of books in Current Toxicology for John Wiley and Sons and Issues in Toxicology for the Royal Society of Chemistry. She is an active Committee member and has been Vice-President of the Institute of Biology. She has successfully supervised 26 PhD students and is currently supervising other PhDs and has managed several post –doctoral positions. She has been external examiner for 29 PhDs and was External Examiner for the Dept. of Genetics, University of Wales, Swansea. She has been invited to speak at many international meetings and chair numerous symposia. She has helped establish new research laboratories in India and Korea under the auspices of the British Council and UNIDO. Funded by various international agencies, scientists from America, Australia, the Czech Republic, Italy, India, Iran, Korea, Poland, Serbia, Spain and Turkey have received training under her supervision. She has organized both national and international meetings and was/is a member of various national (e.g. MRC Advisory Board, Veterinary Products Committee) and was of international committees, including the European Union Scientific Committee for Animal Nutrition (SCAN). She recently won a prize as an Enterprise Fellow. She has hosted and participated in 56 meetings for WHO/IPCS. She is a consultant for many international organisations, such as the WHO, NATO, TWAS, UNIDO and the OECD

Cancer, Reproductive toxicology

Dr. Omura (M.D) Yokohama City University, with internship at Toyoko University Hospital, Tokyo and Sc.D. - in Pharmaco-Electrophysiology of Single Cardiac Cells, Columbia University, New York), far-reaching expertise is rooted in a strong academic background involving an unusual combination of fields including experimental physics (B.S. in Applied Physics, Waseda University, Tokyo--the founder of the SONY Corporation graduated from the same Engineering School--and three years in Graduate Experimental Physics, non-matriculated, Columbia University), medical electronics (Research Professor, Department of Electrical Engineering, Manhattan College, where he introduced the first course in Biomedical Electronics), and basic and clinical medicine (Research Fellow in Cardiovascular Surgery, and Residency at the Cancer Research Hospital, Columbia University) from both Western and Oriental perspectives (several teaching and research Professorship appointments at various universities in Japan and the U.S.).

Acupuncture & Electro-Therapeutics Research, Integrative Oncology

Michael Retsky (Ph.D in physics from University of Chicago) made a career change from physics to cancer research. He is Editor-in-Chief of Journal of Bioavailability and Bioequivalence, on staff at Harvard School of Public Health, honorary faculty at University College London, and Prof Adj at UANL, Monterrey, Mexico. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. He is on the board of directors of the Colon Cancer Alliance and has published more than 60 papers in physics and cancer. He has a patent pending for treatment of early stage cancer

cancer research, charged particle optics, early detection of cancer and delayed detection of cancer

Mohamed El-Far, professor of Biochemistry, worked in the field of Cancer-PDT for 35+ years, published 80 peer-reviewed reports. He serving on the editorial boards and Hon Editor to three international journals in Cancer science& Research (USA); acts as UNESCO expert in science and technology. Served as visiting professor to University of California ,Utah laser center also Mayo clinic for several years. He is a member of International Photodynamic Association and Royal Society of Chemistry, UK. Selected as expert and consultant for biochemistry in the national committee of suprime council of Universities in Egypt, this is the highest nation honor.

Biochemistry